UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

JAMA : the journal of the American Medical Association, 2011-08, Vol.306 (7), p.711

2011

Volltextzugriff (PDF)

Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial

Journal of dermatology, 2017-08, Vol.44 (8), p.873-884

2017

Volltextzugriff (PDF)

Quality of life and disability in patients with treatment-failure gout

Journal of rheumatology, 2009-05, Vol.36 (5), p.1041-1048

2009

Volltextzugriff (PDF)

Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout

Journal of clinical pharmacology, 2008-06, Vol.48 (6), p.708-718

2008

Volltextzugriff (PDF)

Efficacy and safety of Apremilast in Japanese patients with moderate to severe psoriasis: 68-week results from a phase 2b randomized trial

Journal of dermatological science, 2017-05, Vol.86 (2), p.e8-e8

2017

Volltextzugriff (PDF)

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study

Arthritis and rheumatism, 2008-09, Vol.58 (9), p.2882-2891

2008

Volltextzugriff (PDF)

Resolution of gouty tophi after twelve weeks of pegloticase treatment

Arthritis and rheumatism, 2008-11, Vol.58 (11), p.3632-3634

2008

Volltextzugriff (PDF)

Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.1-8

1997

Volltextzugriff (PDF)

Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia

Clinical therapeutics, 1997-09, Vol.19 (5), p.975-988

1997

Volltextzugriff (PDF)

Theophylline and warfarin interaction studies with grepafloxacin

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.39-46

1997

Volltextzugriff (PDF)

Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men

Antimicrobial agents and chemotherapy, 1997-08, Vol.41 (8), p.1843-1845

1997

Volltextzugriff (PDF)

Effect of age and gender on the pharmacokinetics of grepafloxacin

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.9-17

1997

Volltextzugriff (PDF)

Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site‐specific immunoconjugates

Cancer, 1993-12, Vol.72 (S11), p.3453-3462

1993

Volltextzugriff (PDF)

Effect of food and gastric pH on the bioavailability of grepafloxacin

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.18-24

1997

Volltextzugriff (PDF)

Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.25-31, Article 25

1997

Volltextzugriff (PDF)

Effect of renal impairment on the pharmacokinetics of grepafloxacin

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.32-38

1997

Volltextzugriff (PDF)

Immunoscintigraphy with111 In-satumomab pendetide in patients with colorectal adenocarcinoma: Performance and impact on clinical management

Diseases of the colon & rectum, 1994-02, Vol.37 (2), p.129-137

1994

Volltextzugriff (PDF)

INFLUENCE OF MORPHINE ON THE DISCRIMINATIVE STIMULUS PROPERTIES OF REWARDING LATERAL HYPOTHALAMIC STIMULATION

MAROLI, ALLAN NORMAN

1980

Volltextzugriff (PDF)

Parametric effects in the discrimination of intracranial stimulation: Some methodological and analytical issues

Physiology & behavior, 1982-06, Vol.28 (6), p.1047-1058

1982

Volltextzugriff (PDF)

Facilitation of self-stimulation in rats by methadone

Pharmacology, biochemistry and behavior, 1980-12, Vol.13 (6), p.919-924

1980

Volltextzugriff (PDF)

Intensity generalization with positively reinforcing intracranial stimulation

Physiology & behavior, 1978-10, Vol.21 (4), p.531-535

1978

Volltextzugriff (PDF)

Morphine and self-stimulation: Evidence for action on a common neural substrate

Pharmacology, biochemistry and behavior, 1978-02, Vol.8 (2), p.119-123

1978

Volltextzugriff (PDF)

Self-administration of the analgesic suprofen in arthritic rats: Evidence of [formula omitted]-induced arthritis as an experimental model of chronic pain

Life sciences (1973), 1980-09, Vol.27 (11), p.921-928

1980

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial

Quality of life and disability in patients with treatment-failure gout

Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout

Efficacy and safety of Apremilast in Japanese patients with moderate to severe psoriasis: 68-week results from a phase 2b randomized trial

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study

Resolution of gouty tophi after twelve weeks of pegloticase treatment

Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males

Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia

Theophylline and warfarin interaction studies with grepafloxacin

Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men

Effect of age and gender on the pharmacokinetics of grepafloxacin

Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site‐specific immunoconjugates

Effect of food and gastric pH on the bioavailability of grepafloxacin

Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction

Effect of renal impairment on the pharmacokinetics of grepafloxacin

Immunoscintigraphy with111 In-satumomab pendetide in patients with colorectal adenocarcinoma: Performance and impact on clinical management

INFLUENCE OF MORPHINE ON THE DISCRIMINATIVE STIMULUS PROPERTIES OF REWARDING LATERAL HYPOTHALAMIC STIMULATION

Parametric effects in the discrimination of intracranial stimulation: Some methodological and analytical issues

Facilitation of self-stimulation in rats by methadone

Intensity generalization with positively reinforcing intracranial stimulation

Morphine and self-stimulation: Evidence for action on a common neural substrate

Self-administration of the analgesic suprofen in arthritic rats: Evidence of [formula omitted]-induced arthritis as an experimental model of chronic pain

Suchergebnisse filtern